The Venture Codex Logo

The Venture Codex

ArsenalBio

329 Oyster Point Blvd, South San Francisco, California, 94080, United States

Overview

Programmable cell therapy company developing immune cell therapies.

Total Raised

$630 M

Rounds

3

Links

Verticals

Biotechnology
Cloud Computing
Life Science
Medical

Investment History

  1. Series C

    Sep 2024

    $325M

    SoftBankWestlake Village BioPartnersARCH Venture PartnersBristol Myers SquibbHitachi VenturesT. Rowe Price AssociatesKleiner PerkinsParker Institute for Cancer ImmunotherapyNVenturesLuma GroupRock Springs Capital

  2. Series B

    Sep 2022

    $220M

    University of California, San FranciscoGreen Sands EquityParker Institute for Cancer ImmunotherapyEmerson CollectiveWestlake Village BioPartnersBristol Myers SquibbKleiner PerkinsSixth Street GrowthSoftBankHitachi Ventures

  3. Series A

    Oct 2019

    $85M

    Osage Venture PartnersUniversity of California, San FranciscoKleiner PerkinsWestlake Village BioPartnersParker Institute for Cancer Immunotherapy

Team

Ken Drazan

Chairman, CEO, Co-Founder

W. Nicholas Haining

Co-Founder & Chief Scientific Officer

Tarjei Mikkelsen

Chief Technology Officer

Meg Nibbi

Chief Legal Officer and Corporate Secretary